Q1 2024 13F Holders as of 3/31/2024
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
32.6M
-
Number of holders
-
51
-
Total 13F shares, excl. options
-
15.9M
-
Shares change
-
+15.9M
-
Total reported value, excl. options
-
$245M
-
Value change
-
+$245M
-
Number of buys
-
50
-
Price
-
$15.35
Significant Holders of Alto Neuroscience, Inc. - Common Stock, $0.0001 par value per share (ANRO) as of Q1 2024
52 filings reported holding ANRO - Alto Neuroscience, Inc. - Common Stock, $0.0001 par value per share as of Q1 2024.
Alto Neuroscience, Inc. - Common Stock, $0.0001 par value per share (ANRO) has 51 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 15.9M shares
of 32.6M outstanding shares and own 48.97% of the company stock.
Largest 10 shareholders include Alpha Wave Global, LP (3.71M shares), FMR LLC (2.35M shares), RA CAPITAL MANAGEMENT, L.P. (1.39M shares), Point72 Asset Management, L.P. (1.13M shares), 72 Investment Holdings, LLC (668K shares), PRICE T ROWE ASSOCIATES INC /MD/ (638K shares), FRANKLIN RESOURCES INC (625K shares), ExodusPoint Capital Management, LP (607K shares), Deep Track Capital, LP (600K shares), and VANGUARD GROUP INC (536K shares).
This table shows the top 51 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.